These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 19195801)

  • 1. Towards understanding the neuronal ceroid lipofuscinoses.
    Kohlschütter A; Schulz A
    Brain Dev; 2009 Aug; 31(7):499-502. PubMed ID: 19195801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. You say lipofuscin, we say ceroid: defining autofluorescent storage material.
    Seehafer SS; Pearce DA
    Neurobiol Aging; 2006 Apr; 27(4):576-88. PubMed ID: 16455164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batten disease: four genes and still counting.
    Mole SE
    Neurobiol Dis; 1998 Nov; 5(5):287-303. PubMed ID: 10069573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel CLN8 mutations confirm the clinical and ethnic diversity of late infantile neuronal ceroid lipofuscinosis.
    Reinhardt K; Grapp M; Schlachter K; Brück W; Gärtner J; Steinfeld R
    Clin Genet; 2010 Jan; 77(1):79-85. PubMed ID: 19807737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatic perspectives in the neuronal ceroid lipofuscinoses.
    Kmoch S; Stránecký V; Emes RD; Mitchison HM
    Biochim Biophys Acta; 2013 Nov; 1832(11):1831-41. PubMed ID: 23274885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin D-deficient Drosophila recapitulate the key features of neuronal ceroid lipofuscinoses.
    Myllykangas L; Tyynelä J; Page-McCaw A; Rubin GM; Haltia MJ; Feany MB
    Neurobiol Dis; 2005; 19(1-2):194-9. PubMed ID: 15837574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal ceroid lipofuscinoses.
    Chabrol B; Caillaud C; Minassian B
    Handb Clin Neurol; 2013; 113():1701-6. PubMed ID: 23622391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic modifiers of degeneration in the cathepsin D deficient Drosophila model for neuronal ceroid lipofuscinosis.
    Kuronen M; Talvitie M; Lehesjoki AE; Myllykangas L
    Neurobiol Dis; 2009 Dec; 36(3):488-93. PubMed ID: 19761846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuronal ceroid lipofuscinoses].
    Augestad LB; Diderichsen J
    Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1908-10. PubMed ID: 16915312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological progress. The neuronal ceroid lipofuscinoses: a review.
    Boustany RM; Kolodny EH
    Rev Neurol (Paris); 1989; 145(2):105-10. PubMed ID: 2657976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
    Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
    Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Funduscopic and angiographic appearance in the neuronal ceroid lipofuscinoses.
    Hainsworth DP; Liu GT; Hamm CW; Katz ML
    Retina; 2009 May; 29(5):657-68. PubMed ID: 19289983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal degeneration in retinitis pigmentosa and neuronal ceroid lipofuscinosis: An overview.
    Birch DG
    Mol Genet Metab; 1999 Apr; 66(4):356-66. PubMed ID: 10191129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy.
    Ranta S; Topcu M; Tegelberg S; Tan H; Ustübütün A; Saatci I; Dufke A; Enders H; Pohl K; Alembik Y; Mitchell WA; Mole SE; Lehesjoki AE
    Hum Mutat; 2004 Apr; 23(4):300-5. PubMed ID: 15024724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.
    Warrier V; Vieira M; Mole SE
    Biochim Biophys Acta; 2013 Nov; 1832(11):1827-30. PubMed ID: 23542453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental gene therapies for the NCLs.
    Liu W; Kleine-Holthaus SM; Herranz-Martin S; Aristorena M; Mole SE; Smith AJ; Ali RR; Rahim AA
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165772. PubMed ID: 32220628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosis.
    Wong AM; Rahim AA; Waddington SN; Cooper JD
    Biochem Soc Trans; 2010 Dec; 38(6):1484-8. PubMed ID: 21118112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells.
    Lonka L; Salonen T; Siintola E; Kopra O; Lehesjoki AE; Jalanko A
    J Neurosci Res; 2004 Jun; 76(6):862-71. PubMed ID: 15160397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal ceroid lipofuscinoses: classification and diagnosis.
    Wisniewski KE; Kida E; Golabek AA; Kaczmarski W; Connell F; Zhong N
    Adv Genet; 2001; 45():1-34. PubMed ID: 11332767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic analysis of neuronal ceroid lipofuscinosis.
    Mole SE; Gardiner M
    Int J Neurol; 1991-1992; 25-26():52-9. PubMed ID: 11980063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.